Trial intelligence / Profile preview

Olanzapine versus alprazolam for perioperative anxiety in primary and revision total joint arthroplasty

ChiCTR2400083398Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of olanzapine and alprazolam in Perioperative anxiety, hip osteoarthritis and disorders of knee (5 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: State-Trait Anxiety Inventory-State score. Planned start Apr 2024; status: not yet recruiting.

02

Drugs

olanzapinealprazolam
03

Conditions

Perioperative anxietyhip osteoarthritisdisorders of knee

Beyond the preview

Go deeper on ChiCTR2400083398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call